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Background
Hypoxic ischemic encephalopathy, also named as HIE, is one type of brain damage 
caused by prolonged insufficient blood and oxygen supply (Fatemi et al. 2009). HIE in 
the perinatal period is one of the most important factors leading to cerebral palsy and 
associated disabilities in children (Fatemi et al. 2009), while cerebral palsy is one of the 
most costly neurologic disabilities with an incidence of 0.2% in neonates of USA and can 
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labeled with I125 was injected into adult rats, neonatal rats and HI neonatal rats via tail 
vein. The radioactivity of brain tissue and blood was examined and analyzed 30 min 
after injection. Also, brain regions including the basal forebrain, frontal cortex, hip-
pocampus, hypothalamus, cerebellum, bulbus olfactorius and hypophysis, of all the 
rats were dissected and radioactivity was examined to investigate the spatial specificity 
of NGF permeation through BBB.
Results: Statistically significant results were observed in I125-β-NGF contents in brain 
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widely distributed in basal forebrain, frontal cortex, hippocampus, cerebellum and 
bulbus olfactorius. But the radioactivity in frontal cortex, hippocampus and cerebellum 
of HI groups are statistically higher than control groups (P < 0.05).
Conclusion: β-NGF can more easily penetrate the BBB of newborn rats than adult rats 
via peripheral venous administration and this effect can be enhanced by HI insult. Also, 
this HI-induced permeation of β-NGF through BBB is more obvious in frontal cortex, 
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persists for a whole life for the affected children. The options for the treatment in HIE 
are quite limited and most of them are only supportive therapies including seizure con-
trol, blood pressure control and etc.
Nerve growth factor is a neurotrophic factor and neuropeptide. Interestingly, studies 
(Cortazzo et  al. 1996; Nguyen et  al. 2010; Satoh et  al. 1999) found that nerve growth 
factor (NGF) can prevent apoptosis of neuron cells including the neural crest cells (Cor-
tazzo et al. 1996; Satoh et al. 1999) and hippocampal cells (Nguyen et al. 2010). Mecha-
nisms include the enhancement of superoxide anion production and suppression of 
hydrogen peroxide, and blockage of apoptotic cascade (Cortazzo et  al. 1996; Nguyen 
et al. 2010). Also, Lindvall et al. (1994) found that brain damage can lead to an increase 
of endogenous NGF, which may contribute to nerve protection effect (Fan et al. 2007). In 
normal physiological conditions, NGF is one of the nerve cell growth regulatory factors 
involved in the proliferation, maintenance and survival in the neural cells, and is main-
tained at a moderately low level in the brain. In spite of the protective role of endoge-
nous NGF in hypoxic insults or other damage of brain, the endogenous NGF is still quite 
limited and is difficult to exert long-lasting protection from the damage (O’Driscoll and 
Gorman 2005; Lindvall et al. 1992).
As the development of natural model NGF and β-NGF-cDNA cloned, exogenous NGF 
came to be an available therapeutic agent for neurological diseases (Bowes et al. 2000; 
Lorigados Pedre et al. 2002). Even though NGF is only 12 kDa in its mature form, it’s still 
hard for NGF to penetrate through Blood–Brain-Barrier (BBB). However, as a potential 
nerve cell protectant, whether and when NGF can better penetrate the blood brain bar-
rier or be absorbed by the brain tissue is still controversial. In this paper, we studied the 
permeability of β-NGF through BBB and examined the absorption and distribution of 




β-NGF, I125, Sephadex G-25 medium, RSS-5100 portable digital oxygen meter, FT-
613-automatic I125 radioactivity meter, Electronic scale, 70–80 days adult Wistar Rats, 
neonatal Wistar rats (7 days after birth). All animal experiments were approved by the 
Ethics Committee of the First Hospital of Jinlin University in Changchun, Jilin. All data 
were represented as mean ± SD.
I125 labeling of β‑NGF
Chloramine T method: 118.6 µg β-NGF, 100 ml chloramine T fluid (0.01 mol/L, pH 7.2, 
dissolved in PBS) and 2 mCi I125 were mixed at room temperature allowing the reaction 
to proceed for 3 min. Then 400 µl NaS2O2 was added into the system allowing to pro-
ceed for 1 min at room temperature to terminate the reaction. The mixture was then fil-
tered through glucan coagulation G-25 column and the elution from equilibrium liquid 
was collected. 10% trichloroacetic precipitation method was used to measure the label-
ling efficiency. Merge labelling rate ≥83.367% elution with the specific activity at 14.0585 
uCi/ug was collected and stored at 4 °C.
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The establishment of HI brain damage model
An atmospheric oxygen cabin sized at 40 × 50 × 60 cm was made with two 2 × 2 cm 
holes on both sides. Electric blanket tank was used to control the environment tem-
perature and soda lime was used to absorb moisture and CO2. The air within the 
cabin was monitored by nitrogen and oxygen conditioning test instrument (temper-
ature is 36 ±  1  °C, oxygen concentration at 8%). Neonatal rats was kept in the cabin 
under hypoxic condition for 1.5 h discontinued with normoxic condition. After anoxia 
30–60 min all rats manifested as cyanosis, head shaking, limb jitterring and hyperactiv-
ity. When we do HE-staining HI manifestations such as swelling, shrivel, depigmenta-
tion and bleeding can be seen (Fig. 1).
Demographic details of each group and injection dosage
Part 1: overall radioactivity assessment
Adult rats group: 8 rats, 70–80 days, weight to 200.4 ± 10.1 g, tail vein injection of I125-
β-NGF 5ug/kg; normal neonatal rats group: 8 rats, born in 7 days, weight 15.8 ± 1.4 g, 
intravenous injection I125-β-NGF 5ug/kg; HI neonatal rats group: 8 rats, born in 7 days, 
weight 15.2 ± 1.6 g, intravenous injection I125-β-NGF 5ug/kg.
Part 2: tissue specific radioactivity assessment
HI group: 16 rats, born in 7 days, weight 14.9 ± 1.7 g, hypoxia model, 8 rats to inject I125-
β-NGF, and 8 rats to inject I125.
Control group: 16 rats, born in 7 days, weight 15.1 ± 1.6 g, no HI intervention, 8 rats 
to inject I125-β-NGF, and 8 rats to inject I125.
Experimental design
Part 1: overall radioactivity assessment
After the 30 min hypoxic treatment (or control treatment), adult rats group, HI neonatal 
group and control neonatal group were isoflurane anesthetized and euthanized by jugu-
lar vein bloodletting method. The pia mater were removed carefully followed by brain 
tissue separation and blood collection at the same time. The blood and brain tissue were 
weighed by electronic scales and the radioactivity of each rat was measured within 12 h.
Part 2: tissue specific radioactivity assessment
After 30 min pre-treatment and all rats were isoflurane anesthetized and sacrificed, dif-
ferent brain parts of the rats were dissected on ice including olfactory bulb, the frontal 
Fig. 1 The illustration of neonatal HI rats nerve cells’ swelling with vacuoles formation (a), depigmentation (a) 
and hemorrhage with red blood cells leakage from the blood vessel (b) in hippocampus of rat. Also, the brain 
section of healthy neonatal rat is shown in c
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cortex, hippocampus, thalamus region, the cerebellum, the pituitary gland. Gamma free 
analyzer was adopted for radioactivity measurement.
Part 3: apoptotic analysis via TUNEL assay
After radioactivity measurement of all the brain tissues, samples were collected for 0.4% 
paraformaldehyde fixation for 15  min followed with paraffin-wax embedding. Slides 
were cut and stained with H&E staining and Terminal deoxynucleotidyl transferase 
(TdT) dUTP Nick-End Labeling (TUNEL) assay, as described by the protocol from the 
kit (MK1020, Boster, Wuhan, China).
Statistical analysis
SPSS17.0 statistic software was used for data analysis and one-way ANOVA was used to 
decide the statistical significance. All experiments involved were repeated at least three 
times and data in this paper were shown as mean ± SD. A P value less than 0.05 is set to 
be statistically significant.
Results
Part 1: overall I125‑β‑NGF level in brain and blood of each group
Table 1 suggest there are significant difference (P < 0.05) of I125-β-NGF content in adult 
rats (51.21  ±  3.40  Ci/g), normal neonatal rats (130.74  ±  6.84  Ci/g) and neonatal HI 
rats (165.83 ± 8.74 Ci/g), among of which the neonatal HI group (165.83 ± 8.74 Ci/g) 
has the highest level of radioactivity (Fig.  2a). In the meantime, after normaliza-
tion with blood I125-β-NGF (adult rats: 1798.61 ±  116.66  Ci/g; Normal neonatal rats: 
1908.96 ± 62.71 Ci/g; Neonatal HI rats: 899.89 ± 162.96 Ci/g), brain I125-β-NGF of the 
adult rats group (2.86 ± 0.25%) is the lowest, normal neonatal rats group (6.85 ± 0.50%) 
take the second place, and neonatal HI rats group (8.75 ± 0.33%) is the highest (P < 0.05) 
(Fig. 2b).
Part 2: I125‑β‑NGF distribution in the brain of neonatal rats
In normal control group, I125-β-NGF absorption was obviously higher than that of I125 in 
the basal forebrain (1273.333 ± 376.600 vs 518.000 ± 61.454 counts/min), frontal cortex 
(1185.500 ± 371.714 vs 443.833 ± 101.075 counts/min), cerebellum (2505.000 ± 665.695 
vs 745.000  ±  100.349 counts/min), hippocampus (1686.833  ±  534.053 vs 
628.000  ±  140.274 counts/min), and olfactory bulb (1672.667  ±  500.930 vs 
629.000  ±  105.284 counts/min) (P  <  0.05); I125-β-NGF in HI group absorb obviously 
higher than that of I125 in the basal forebrain (1845.667 ± 534.705 vs 767.833 ± 116.393 
Table 1 The I125-β NGF level in brain and blood by vein injection (Ci/g, n=8)
The adult rats’ brain can detain the fewest NGF at (2.86 ± 0.25)%, normal neonatal rats ranked the middle at (6.85 ± 0.50)% 
and neonatal HI rats can detain the most NGF at (8.75 ± 0.33)%
# versus ** P < 0.05; # versus * P < 0.01; ** versus * P < 0.05
Group Adult rats Normal neonatal rats Neonatal HI rats
Brain 51.21 ± 3.40# 130.74 ± 6.84** 165.83 ± 8.74*
Blood 1798.61 ± 116.66 1908.96 ± 62.71 899.89 ± 162.96
Percentage% 2.86 ± 0.25# 6.85 ± 0.50** 8.75 ± 0.33*
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counts/min), frontal cortex (3151.333  ±  872.215 vs 928.000  ±  130.545 counts/min), 
cerebellum (4243.833  ±  1097.127 vs 1001.000  ±  203.048 counts/min), hippocam-
pus (2736.167  ±  873.323 vs 637.000  ±  151.060 counts/min), and olfactory bulb 
(2036.167 ± 620.084 vs 715.000 ± 130.026 counts/min) (P < 0.05) (Fig. 3; Table 2).
I125-β-NGF in HI group absorb obviously higher than that of I125-β-NGF in normal 
control group in the frontal cortex (3151.333 ± 872.215 vs 1185.500 ± 371.714 counts/
min), cerebellum (4243.833  ±  1097.127 vs 2505.000  ±  665.695 counts/min) and hip-
pocampus (2736.167  ±  873.323 vs 1686.833  ±  534.053 counts/min) (P  <  0.05). NGF 
HI group absorb in the basal forebrain (1845.667  ±  534.705 vs 1273.333  ±  376.600 
counts/min), hypothalamus (919.000  ±  145.213 vs 789.333  ±  123.072 counts/min), 
Fig. 2 The comparison of I125-β-NGF level in brain via vein injection. The I125-β-NGF level in the brain of adult 
rats, normal neonatal rats and neonatal HI rats were determined quantitatively and neonatal HI rats would 
detain the most I125-β-NGF, while adult rats detain the least (a). Similar difference in the retention rate were 
found as we normalized the radioactivity of the brain to the blood between these three groups (b). (*P < 0.05; 
**P < 0.01)
Fig. 3 Comparison of radioactivity absorption in different brain regions. I125-β-NGF absorption was higher 
than that of I125 in the basal forebrain, frontal cortex, cerebellum, hippocampus, and olfactory bulb; I125-β-
NGF in HI group absorb obviously higher than that of I125 in the basal forebrain, frontal cortex, cerebellum, 
hippocampus, and olfactory bulb. No statistically significant difference were observed in other regions of the 
brain (*P < 0.05)
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olfactory bulb (2036.167 ± 620.084 vs 1672.667 ± 500.930 counts/min) and hypophysis 
(936.500 ± 184.183 vs 796.333 ± 89.189 counts/min) have no obvious difference to NGF 
normal group in the above areas (Fig. 3, Table 2).
Part 3: NGF supplement ameliorated the apoptosis in the hippocampus region
As shown in Fig. 4, there are much more cells undergoing apoptosis after HI insult in 
the brain. Also, as we apply NGF in the neonatal HI group, we found the apoptosis in 
the hippocampus of neonatal HI group with NGF injection is much milder compared to 
control group with only I125 injection. In addition, the injection of NGF in the adult rats 
group does not made any changes in the hippocampus region.
Discussion
Up to date, consensus has been reached in the  therapeutic use of NGF via peripheral 
vein in the repair and regeneration in central nervous system (Kamei et al. 2007; Gould 
et al. 2000; Ferenz et al. 2012). However, because of the uniqueness of central nervous 
system, the blood-cerebrospinal barrier or blood–brain barrier (BBB) makes it ineffec-
tive for most drugs entering the brain (Smith et al. 2004). At present, most of the experi-
ments use the embedded method or lateral ventricle injection, which requires intensive 
staff training and the successful rate of which largely depend on the operators’ skill. Also, 
Table 2 Comparison of radioactivity absorption in different brain regions (counts per min-
ute, x¯ ± s)
I125‑β‑NGF absorption was obviously higher than that of I125 in the basal forebrain, frontal cortex, cerebellum, hippocampus, 
and olfactory bulb (P < 0.05); I125‑β‑NGF in HI group absorb obviously higher than that of I125 in the basal forebrain, frontal 
cortex, cerebellum, hippocampus, and olfactory bulb (P < 0.05)
BF basal forebrain, CF frontal cortex, CB cerebellum, HF hypocampus, HY hypothalamus, OB bulbus olfactorius, PI hypophysis
Brain region Control group HI group
I125‑NGF I125 I125‑NGF I125
BF 1273.333 ± 376.600 518.000 ± 61.454 1845.667 ± 534.705 767.833 ± 116.393
CF 1185.500 ± 371.714 443.833 ± 101.075 3151.333 ± 872.215 928.000 ± 130.545
CB 2505.000 ± 665.695 745.000 ± 100.349 4243.833 ± 1097.127 1001.000 ± 203.048
HF 1686.833 ± 534.053 628.000 ± 140.274 2736.167 ± 873.323 637.000 ± 151.060
HY 789.333 ± 123.072 595.333 ± 145.446 919.000 ± 145.213 686.500 ± 131.991
OB 1672.667 ± 500.930 629.000 ± 105.284 2036.167 ± 620.084 715.000 ± 130.026
PI 796.333 ± 89.189 684.333 ± 93.520 936.500 ± 184.183 755.333 ± 94.118
Fig. 4 The TUNEL assay in the hippocampus region of the adult normal rats with NGF injection, the neonatal 
normal rats with NGF injection, the neonatal HI rats with NGF injection, neonatal HI rats with PBS injection
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lateral ventricular injection would lead to cerebral edema and increase the risk of infec-
tion, therefore its clinical application is greatly limited. Before the start of this study, we 
made a preliminary investigation on NGF level in adult rat’s brain tissues  after intra-
venous injection and it showed that fractional amount of NGF pass through the blood 
brain barrier after peripheral injection of NGF, and the peak can only be achieved 30 min 
after intravenous injection (data not shown).
The result indicates that, the BBB permeability of NGF in  newborn rat is far better 
than that of adult rats after intravenous injection, especially in hypoxic state. Also, in the 
study of NGF’s spatial distribution in different brain regions, we noticed that the uptake 
of I125-NGF in normal group and hypoxia group was obviously higher than that of I125 in 
the basal forebrain, frontal cortex, cerebellum, hippocampus and olfactory bulb, sug-
gesting that NGF can overtly penetrating the blood–brain barrier in these brain areas. 
Moreover, I125-NGF hypoxia group absorption is significantly higher than normal con-
trol group  in the frontal cortex, hippocampus and cerebellum (P  <  0.05). This finding 
demonstrates that the newborn rat under hypoxia condition have better permeability of 
blood brain barrier to NGF thus it’s might be efficacious to administer venous NGF for 
neonates with hypoxic ischemic encephalopathy (HIE).
The mechanism of HI-neonates brain’s high permeable BBB can be explained as fol-
lows: (1) BBB is not intact in physiological state. There are different defects on BBB in 
areas as median eminence, the hypothalamus endplate vascular bed, sub-dome and 
choroid area. NGF may go through these areas into the brain tissue. (2) Hafny found 
that NGF may activate the  gamma transpeptidase glutamic acid and alkaline phos-
phatase in BBB endothelial cells, which can transform those “guardian cells” of BBB into 
the transfer state (el Hafny et  al. 1996). (3) The BBB of newborn rat is still immature 
thus more permeable to substances as NGF. (4) Recently Moser et al. (2004), Calza et al. 
(2001) prove that NGF can act as a angiogenic factor or indirectly interact with VEGF, 
promoting the proliferation of brain capillary endothelial cells and selectively induc-
ing angiogenesis after cerebral ischemia, thus making the brain vessels more active in a 
pathophysiological state. (5) In hypoxic condition, a large number of free radicals would 
damage the integrity endothelial cells and glial cells’ membrane thus damaging blood–
brain barrier. Also, some special transport mechanisms (Arnett et al. 2007) in HI state 
as unsaturated diffusion (depending on the bond energy of hydrogen bonding), satura-
tion transport system (for a specific carrier) and etc. would make peripheral peptide 
drugs pass through the BBB possible (Zhang et al. 1999). In our experiment, exogenous 
NGF can pass through the blood brain barrier in normal state and anoxic state, and in 
both circumstances it can be absorbed in Cornu Ammonis significantly. So does in the 
cerebral cortex, the olfactory bulb, the basal forebrain and cerebellum, the distribu-
tion of which are basically the same with endogenous NGF in physiological condition 
(Tian et al. 2012). However, the endogenous NGF react differently in neonatal rats with 
hypoxia injury as compared to adult rats in the same condition. Compared to adult rats 
in HI state, NGF level drops quickly after hypoxia insult in newborn hippocampus fol-
lowed with delayed increase in cerebellum (Scheepens et al. 2003). Therefore, it is prom-
ising that exogenous NGF can be therapeutic agents when endogenous NGF in early 
stages of HI insult cannot meet the actual need of the brain, by means of which increase 
the survival of neurons and improve the brain function after hypoxia. The application of 
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NGF in early stages of hypoxia can limit neuron’s injury after ischemia (Lee et al. 2008). 
Also, the combination therapy of mesenchymal stem cells and NGF in stroke patients 
might also be promising to improve the life quality of patients (Jiang et al. 2013). While 
for the negative results in our experiments, it is speculated that NGF’s permeation 
through the olfactory bulb, hypothalamus, basal forebrain and hypophysis are still lim-
ited even in HI state. Also, it still cannot be ruled out that the inspection duration of this 
experiments might be too short to get a statistically significant difference.
Therefore, it is still in great need to further investigate the mechanism of BBB in 
hypoxic-ischemic state and enhance the permeability of exogenous NGF, thus improving 
the prognosis of patients with hypoxic and ischemic encephalopathy as strokes.
Conclusion
β-NGF can more easily penetrate the BBB of newborn rats than adult rats via peripheral 
venous administration and can be enhanced by HI insult. Also, this HI-induced influx 
of β-NGF through BBB is more obvious in frontal cortex, hippocampus and cerebellum.
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